A subsequent molecular docking study suggested that the insertion of the thio group into the cycloalkane ring and the substitution of a hydrophobic moiety on the phenyl ring could improve the binding interactions between Bcl-2 and diarylpentanoids, thus leading to better anti-cancer activity. The gene discussed is BCL2; the disease is cancer.